Details for Patent: 7,858,662
✉ Email this page to a colleague
Which drugs does patent 7,858,662 protect, and when does it expire?
Patent 7,858,662 protects VEREGEN and is included in one NDA.
This patent has thirty-one patent family members in twenty countries.
Summary for Patent: 7,858,662
Title: | Medicament for the treatment of viral skin and tumour diseases |
Abstract: | The invention relates to a medicament containing a compound of general formula (1), where R.sub.1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C.sub.11-C.sub.21 alkyl, alkylene or alkynyl group, preferably a C.sub.11-C.sub.15 alkyl, alkylene or alkynyl group, particularly a C.sub.11-C.sub.13 alkyl, alkylene or alkynyl group, most preferably a C.sub.13 alkyl group, R2=independently, a straight or branched C.sub.1-C.sub.8 alkyl, alkylene or alkynyl group, preferably a C.sub.1-C.sub.6 alkyl, alkylene or alkynyl group, in particular a C.sub.2-C.sub.4 alkyl, alkylene or alkynyl group, most preferably a C.sub.3 alkyl group, a --[CH.sub.2--(CH.sub.2).sub.m--O].sub.nH group with n=1 to 10, preferably n=1 to 5, m=1 to 5, preferably m=1 to 3, a --CH.sub.2--[CH--(OH)].sub.p[CH.sub.2--(R.sub.3)]-- group, where R.sub.3=independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof. ##STR00001## |
Inventor(s): | Chang; Yunik (Sonoma, CA), Lathrop; Robert (Fort Collins, CO), Bohm; Erwin (Ladenburg, DE), Gander-Meisterernst; Irene (Stockdorf, DE), Greger; Regina (Iffeldorf, DE), Holldack; Johanna (Ebeltoft, DK), Moebius; Ulrich (Gauting-Unterbrunn, DE) |
Assignee: | MediGene AG (Planegg, DE) |
Application Number: | 10/495,889 |
Patent Claim Types: see list of patent claims | Compound; Formulation; Use; |
Drugs Protected by US Patent 7,858,662
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | VEREGEN | sinecatechins | OINTMENT;TOPICAL | 021902-001 | Oct 31, 2006 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF GENITAL WARTS | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,858,662
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 101 56 794 | Nov 19, 2001 |
PCT Information | |||
PCT Filed | November 18, 2002 | PCT Application Number: | PCT/EP02/12919 |
PCT Publication Date: | May 30, 2003 | PCT Publication Number: | WO03/043628 |
International Family Members for US Patent 7,858,662
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 037526 | ⤷ Try a Trial | |||
Austria | 417611 | ⤷ Try a Trial | |||
Australia | 2002356673 | ⤷ Try a Trial | |||
Brazil | 0214256 | ⤷ Try a Trial | |||
Brazil | PI0214256 | ⤷ Try a Trial | |||
Canada | 2466720 | ⤷ Try a Trial | |||
China | 1323660 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |